
    
      This is a collaborative, 4 arms , non randomized clinical trial assessing the use of
      Convalescent Plasma from COVID-19 recovered donors to be used in oncological and
      non-oncological patients with current severe COVID-19 infection or in patients with risk
      factors of major complications secondary to COVID-19 infection
    
  